| ■ New Type Of Smallpox Vaccine Added To U.S. Stockpile | 2010.07.16 |
| The first one million doses of a next-generation smallpox vaccine have been added to the U.S. national stockpile. The federal government has ordered 20 million doses of the new vaccine, called Imvamune. These doses are reserved for people with weakened immune systems because conventional smallpox vaccine isn't safe for them, the Associated Press reported. Imvamune, made by a Danish company, was developed in part with U.S. research money as part of the nation's efforts to prepare for a possible bioterrorist attack. The conventional smallpox vaccine is made with a live virus that's related to the smallpox virus. Imvamune is made with a different strain of the virus that can't multiple in human cells. |